SILEEN DOWIS: Open Payments
NPI 1326396904 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$26,627 in 162 payments from 21 companies in 2025. Trend: 2023 $23,528 · 2024 $42,114 · 2025 $26,627
Honoraria: $19,525Travel & lodging: $3,983Food & beverage: $2,894Education: $226
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 33 | $23,977 |
| ABBVIE INC. | 28 | $520 |
| UCB, Inc. | 17 | $360 |
| Incyte Corporation | 10 | $275 |
| Regeneron Healthcare Solutions, Inc. | 13 | $244 |
| Janssen Biotech, Inc. | 8 | $235 |
| Novartis Pharmaceuticals Corporation | 10 | $226 |
| E.R. Squibb & Sons, L.L.C. | 13 | $191 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 5 | $94 |
| Lilly USA, LLC | 4 | $79 |
Products named: VTAMA, Bimzelx, SKYRIZI, Opzelura, DUPIXENT, TREMFYA, Sotyktu, RINVOQ.
Industry payments across MO — which companies pay providers there.
